期刊论文详细信息
Respiratory Research
Use of almitrine in spontaneously breathing patients with COVID-19 treated with high-flow nasal cannula oxygen therapy and with persistent hypoxemia
Correspondence
Clément Saccheri1  Romain Lombardi1  Raphaël Devanlay1  Hervé Hyvernat1  Lucas Morand1  Denis Doyen1  Marie Juston1  Émilie Panicucci1  Jean Dellamonica1  Mathieu Jozwiak1 
[1] Service de Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nice, Hôpital L’Archet 1, 151 Rue Saint Antoine de Ginestière, 06200, Nice, France;Équipe 2 CARRES, UR2CA - Unité de Recherche Clinique Côte d’Azur, Université Côte d’Azur, Nice, France;
关键词: Acute respiratory distress syndrome;    Awake prone positioning;    COVID-19;    Mechanical ventilation;    Oxygenation;   
DOI  :  10.1186/s12931-022-02308-y
 received in 2022-11-21, accepted in 2022-12-29,  发布年份 2022
来源: Springer
PDF
【 摘 要 】

BackgroundAlmitrine, a selective pulmonary vasoconstrictor in hypoxic area, improves oxygenation in mechanically ventilated patients with COVID-19 but its effects in spontaneously breathing patients with COVID-19 remain to be determined.MethodsWe prospectively studied the effects of almitrine (16 µg/kg/min over 30 min followed by continuous administration in responders only) in 62 patients (66% of male, 63 [53–69] years old) with COVID-19 treated with high-flow nasal cannula oxygen therapy (HFNO) and with persistent hypoxemia, defined as a PaO2/FiO2 ratio < 100 with FiO2 > 80% after a single awake prone positioning session. Patients with an increase in PaO2/FiO2 ratio > 20% were considered as responders.ResultsOverall, almitrine increased the PaO2/FiO2 ratio by 50% (p < 0.01), decreased the partial arterial pressure of carbon dioxide by 7% (p = 0.01) whereas the respiratory rate remained unchanged and 46 (74%) patients were responders. No patient experienced right ventricular dysfunction or acute cor pulmonale. The proportion of responders was similar regardless of the CT-Scan radiological pattern: 71% for the pattern with predominant ground-glass opacities and 76% for the pattern with predominant consolidations (p = 0.65). Responders had lower intubation rate (33 vs. 88%, p < 0.01), higher ventilator-free days at 28-day (28 [20–28 ] vs. 19 [2–24] days, p < 0.01) and shorter ICU length of stay (5 [3–10] vs.12 [7–30] days, p < 0.01) than non-responders.ConclusionsAlmitrine could be an interesting therapy in spontaneously breathing patients with COVID-19 treated with HFNO and with persistent hypoxemia, given its effects on oxygenation without serious adverse effects regardless of the CT-Scan pattern, and potentially on intubation rate. These preliminary results need to be confirmed by further randomized studies.

【 授权许可】

CC BY   
© The Author(s) 2023

【 预 览 】
附件列表
Files Size Format View
RO202305116133842ZK.pdf 1473KB PDF download
MediaObjects/12888_2022_4462_MOESM1_ESM.docx 2349KB Other download
41116_2022_35_Article_IEq292.gif 1KB Image download
41116_2022_35_Article_IEq301.gif 1KB Image download
41116_2022_35_Article_IEq313.gif 1KB Image download
41116_2022_35_Article_IEq318.gif 1KB Image download
41116_2022_35_Article_IEq319.gif 1KB Image download
【 图 表 】

41116_2022_35_Article_IEq319.gif

41116_2022_35_Article_IEq318.gif

41116_2022_35_Article_IEq313.gif

41116_2022_35_Article_IEq301.gif

41116_2022_35_Article_IEq292.gif

【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  • [30]
  • [31]
  • [32]
  • [33]
  • [34]
  • [35]
  • [36]
  • [37]
  文献评价指标  
  下载次数:8次 浏览次数:0次